{"transactions":[{"id":2070850,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-04T16:33:18.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of shares subject to the option vest on January 30, 2023, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":15000,"derivative":{"exercise_price":47.95,"expiration_date":"2032-12-30","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-000968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919123000968/doc4.xml","form_type":"4"}},{"id":2130712,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-10-28T18:56:04.000Z","date":"2022-10-26","kind":"sale","acquired":false,"shares":10000,"price":40,"value":400000.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":286227,"source":{"system":"sec-edgar","filing":"0001209191-22-054858","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122054858/doc4.xml","form_type":"4"}},{"id":2137951,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-10-13T16:57:57.000Z","date":"2022-10-11","kind":"sale","acquired":false,"shares":5000,"price":25.5,"value":127500.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":296227,"source":{"system":"sec-edgar","filing":"0001209191-22-053579","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122053579/doc4.xml","form_type":"4"}},{"id":2164739,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-09-07T16:37:31.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":336,"price":27.1382,"value":9118.4352,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $27.09 to $27.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":301227,"source":{"system":"sec-edgar","filing":"0001209191-22-049025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122049025/doc4.xml","form_type":"4"}},{"id":2164738,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-09-07T16:37:31.000Z","date":"2022-09-06","kind":"sale","acquired":false,"shares":4664,"price":26.5381,"value":123773.6984,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $26.04 to $27.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":301563,"source":{"system":"sec-edgar","filing":"0001209191-22-049025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122049025/doc4.xml","form_type":"4"}},{"id":2164737,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-09-07T16:37:31.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":519,"price":26.38,"value":13691.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units."}],"balance_after":17143,"source":{"system":"sec-edgar","filing":"0001209191-22-049025","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122049025/doc4.xml","form_type":"4"}},{"id":2193916,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-08-05T19:12:25.000Z","date":"2022-08-05","kind":"sale","acquired":false,"shares":5000,"price":25.7015,"value":128507.5,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.50 to $26.035. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":306227,"source":{"system":"sec-edgar","filing":"0001209191-22-044659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122044659/doc4.xml","form_type":"4"}},{"id":2193915,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-08-05T19:12:25.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":10000,"price":25.5,"value":255000.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":311227,"source":{"system":"sec-edgar","filing":"0001209191-22-044659","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122044659/doc4.xml","form_type":"4"}},{"id":2259023,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-05-24T16:32:59.000Z","date":"2022-05-20","kind":"sale","acquired":false,"shares":4112,"price":25.5,"value":104856.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":321227,"source":{"system":"sec-edgar","filing":"0001209191-22-031619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122031619/doc4.xml","form_type":"4"}},{"id":2278509,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-05-09T16:35:04.000Z","date":"2022-05-05","kind":"sale","acquired":false,"shares":888,"price":25.8045,"value":22914.396,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.58 to $26.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":325339,"source":{"system":"sec-edgar","filing":"0001209191-22-027848","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122027848/doc4.xml","form_type":"4"}},{"id":2301918,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-04-07T17:24:34.000Z","date":"2022-04-05","kind":"sale","acquired":false,"shares":5000,"price":25.59,"value":127950.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":326227,"source":{"system":"sec-edgar","filing":"0001209191-22-023695","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122023695/doc4.xml","form_type":"4"}},{"id":2334396,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-03-15T21:09:47.000Z","date":"2022-03-11","kind":"sale","acquired":false,"shares":10000,"price":25.5,"value":255000.0,"ownership":{"direct":false,"nature":"By Fairman Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":331227,"source":{"system":"sec-edgar","filing":"0001209191-22-019027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122019027/doc4.xml","form_type":"4"}},{"id":2351659,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T20:56:12.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter."}],"balance_after":33000,"derivative":{"exercise_price":24.79,"expiration_date":"2032-03-01","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001209191-22-016524","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122016524/doc4.xml","form_type":"4"}},{"id":2351658,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-03-04T20:56:12.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter."}],"balance_after":16629,"source":{"system":"sec-edgar","filing":"0001209191-22-016524","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122016524/doc4.xml","form_type":"4"}},{"id":2409254,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-08T17:27:10.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"shares":4469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":53626,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4469},"source":{"system":"sec-edgar","filing":"0001209191-22-007789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122007789/doc4.xml","form_type":"4"}},{"id":2409253,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2022-02-08T17:27:10.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":4469,"price":1.79,"value":7999.51,"ownership":{"direct":true},"balance_after":10629,"source":{"system":"sec-edgar","filing":"0001209191-22-007789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919122007789/doc4.xml","form_type":"4"}},{"id":2458184,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-28T16:15:16.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":53345,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-071376","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121071376/doc4.xml","form_type":"4"}},{"id":2458183,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-28T16:15:16.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":175,"price":24.08,"value":4214.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.04 to $24.285. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6160,"source":{"system":"sec-edgar","filing":"0001209191-21-071376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121071376/doc4.xml","form_type":"4"}},{"id":2458182,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-28T16:15:16.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":4575,"price":23.58,"value":107878.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $23.02 to $24.005. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":6335,"source":{"system":"sec-edgar","filing":"0001209191-21-071376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121071376/doc4.xml","form_type":"4"}},{"id":2458181,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-28T16:15:16.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":10910,"source":{"system":"sec-edgar","filing":"0001209191-21-071376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121071376/doc4.xml","form_type":"4"}},{"id":2464566,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-20T16:35:34.000Z","date":"2021-12-16","kind":"exercise","acquired":false,"shares":4619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":58095,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4619},"source":{"system":"sec-edgar","filing":"0001209191-21-070572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121070572/doc4.xml","form_type":"4"}},{"id":2464565,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-20T16:35:34.000Z","date":"2021-12-16","kind":"sale","acquired":false,"shares":4619,"price":22.5,"value":103927.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":6160,"source":{"system":"sec-edgar","filing":"0001209191-21-070572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121070572/doc4.xml","form_type":"4"}},{"id":2464564,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-20T16:35:34.000Z","date":"2021-12-16","kind":"exercise","acquired":true,"shares":4619,"price":1.79,"value":8268.01,"ownership":{"direct":true},"balance_after":10779,"source":{"system":"sec-edgar","filing":"0001209191-21-070572","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121070572/doc4.xml","form_type":"4"}},{"id":2476405,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-12-13T17:20:36.000Z","date":"2021-12-09","kind":"exercise","acquired":false,"shares":131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":62714,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":131},"source":{"system":"sec-edgar","filing":"0001209191-21-069292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121069292/doc4.xml","form_type":"4"}},{"id":2476404,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-13T17:20:36.000Z","date":"2021-12-09","kind":"sale","acquired":false,"shares":131,"price":22.5,"value":2947.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":6160,"source":{"system":"sec-edgar","filing":"0001209191-21-069292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121069292/doc4.xml","form_type":"4"}},{"id":2476403,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-12-13T17:20:36.000Z","date":"2021-12-09","kind":"exercise","acquired":true,"shares":131,"price":1.79,"value":234.49,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,016 shares acquired under the Employee Stock Purchase Plan on November 17, 2021."}],"balance_after":6291,"source":{"system":"sec-edgar","filing":"0001209191-21-069292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121069292/doc4.xml","form_type":"4"}},{"id":2533176,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-10-28T18:00:32.000Z","date":"2021-10-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":62845,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-061940","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121061940/doc4.xml","form_type":"4"}},{"id":2533175,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-10-28T18:00:32.000Z","date":"2021-10-26","kind":"sale","acquired":false,"shares":4750,"price":22.69,"value":107777.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $22.54 to $22.855. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-061940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121061940/doc4.xml","form_type":"4"}},{"id":2533174,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-10-28T18:00:32.000Z","date":"2021-10-26","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":9894,"source":{"system":"sec-edgar","filing":"0001209191-21-061940","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121061940/doc4.xml","form_type":"4"}},{"id":2557140,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-09-29T19:52:21.000Z","date":"2021-09-27","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":67595,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-058125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121058125/doc4.xml","form_type":"4"}},{"id":2557139,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-09-29T19:52:21.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":139,"price":26.47,"value":3679.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-058125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121058125/doc4.xml","form_type":"4"}},{"id":2557138,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-09-29T19:52:21.000Z","date":"2021-09-27","kind":"sale","acquired":false,"shares":4611,"price":26.16,"value":120623.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.415 to $26.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5283,"source":{"system":"sec-edgar","filing":"0001209191-21-058125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121058125/doc4.xml","form_type":"4"}},{"id":2557137,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-09-29T19:52:21.000Z","date":"2021-09-27","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":9894,"source":{"system":"sec-edgar","filing":"0001209191-21-058125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121058125/doc4.xml","form_type":"4"}},{"id":2587385,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-08-30T18:06:58.000Z","date":"2021-08-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":72345,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-053901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121053901/doc4.xml","form_type":"4"}},{"id":2587384,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-08-30T18:06:58.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":3218,"price":25.7,"value":82702.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.06 to $26.015. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-053901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121053901/doc4.xml","form_type":"4"}},{"id":2587383,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-08-30T18:06:58.000Z","date":"2021-08-26","kind":"sale","acquired":false,"shares":1532,"price":24.7,"value":37840.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.06 to $25.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":8362,"source":{"system":"sec-edgar","filing":"0001209191-21-053901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121053901/doc4.xml","form_type":"4"}},{"id":2587382,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-08-30T18:06:58.000Z","date":"2021-08-26","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":9894,"source":{"system":"sec-edgar","filing":"0001209191-21-053901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121053901/doc4.xml","form_type":"4"}},{"id":2623472,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-28T16:32:26.000Z","date":"2021-07-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":77095,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-048429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121048429/doc4.xml","form_type":"4"}},{"id":2623471,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-07-28T16:32:26.000Z","date":"2021-07-26","kind":"sale","acquired":false,"shares":4750,"price":22.7,"value":107825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $22.50 to $22.935. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-048429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121048429/doc4.xml","form_type":"4"}},{"id":2623470,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-07-28T16:32:26.000Z","date":"2021-07-26","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":9894,"source":{"system":"sec-edgar","filing":"0001209191-21-048429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121048429/doc4.xml","form_type":"4"}},{"id":2650921,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-30T17:41:35.000Z","date":"2021-06-28","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":81845,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-044018","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121044018/doc4.xml","form_type":"4"}},{"id":2650920,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-30T17:41:35.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":136,"price":24.8,"value":3372.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.79 to $24.81. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-044018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121044018/doc4.xml","form_type":"4"}},{"id":2650919,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-30T17:41:35.000Z","date":"2021-06-28","kind":"sale","acquired":false,"shares":4614,"price":24.36,"value":112397.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $23.77 to $24.765. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":5280,"source":{"system":"sec-edgar","filing":"0001209191-21-044018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121044018/doc4.xml","form_type":"4"}},{"id":2650918,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-30T17:41:35.000Z","date":"2021-06-28","kind":"exercise","acquired":true,"shares":4750,"price":1.79,"value":8502.5,"ownership":{"direct":true},"balance_after":9894,"source":{"system":"sec-edgar","filing":"0001209191-21-044018","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121044018/doc4.xml","form_type":"4"}},{"id":2676588,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-09T16:53:58.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":2241,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter."}],"balance_after":86595,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":2241},"source":{"system":"sec-edgar","filing":"0001209191-21-039204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121039204/doc4.xml","form_type":"4"}},{"id":2676587,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-09T16:53:58.000Z","date":"2021-06-07","kind":"exercise","acquired":false,"shares":7259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.04,"expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":7259},"source":{"system":"sec-edgar","filing":"0001209191-21-039204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121039204/doc4.xml","form_type":"4"}},{"id":2676586,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-09T16:53:58.000Z","date":"2021-06-07","kind":"sale","acquired":false,"shares":9500,"price":22.5,"value":213750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":5144,"source":{"system":"sec-edgar","filing":"0001209191-21-039204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121039204/doc4.xml","form_type":"4"}},{"id":2676585,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-09T16:53:58.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":2241,"price":1.79,"value":4011.39,"ownership":{"direct":true},"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001209191-21-039204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121039204/doc4.xml","form_type":"4"}},{"id":2676584,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-06-09T16:53:58.000Z","date":"2021-06-07","kind":"exercise","acquired":true,"shares":7259,"price":0.04,"value":290.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 943 shares acquired under the Employee Stock Purchase Plan on May 17, 2021."}],"balance_after":12403,"source":{"system":"sec-edgar","filing":"0001209191-21-039204","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121039204/doc4.xml","form_type":"4"}},{"id":2741256,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-23T19:31:24.000Z","date":"2021-04-22","kind":"exercise","acquired":false,"shares":2793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter."}],"balance_after":88836,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":2793},"source":{"system":"sec-edgar","filing":"0001209191-21-028190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121028190/doc4.xml","form_type":"4"}},{"id":2741255,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-04-23T19:31:24.000Z","date":"2021-04-22","kind":"exercise","acquired":true,"shares":2793,"price":1.79,"value":4999.47,"ownership":{"direct":true},"balance_after":4201,"source":{"system":"sec-edgar","filing":"0001209191-21-028190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121028190/doc4.xml","form_type":"4"}},{"id":2756274,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-04-06T20:10:12.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48 of shares subject to the option vest on May 1, 2021, and 1/48 of the shares vest monthly thereafter."}],"balance_after":40000,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-21-025763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121025763/doc4.xml","form_type":"4"}},{"id":2769985,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-29T19:18:35.000Z","date":"2021-03-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":7259,"derivative":{"exercise_price":0.04,"expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-023482","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121023482/doc4.xml","form_type":"4"}},{"id":2769984,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-29T19:18:35.000Z","date":"2021-03-26","kind":"sale","acquired":false,"shares":1361,"price":24.48,"value":33317.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.15 to $24.77. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1408,"source":{"system":"sec-edgar","filing":"0001209191-21-023482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121023482/doc4.xml","form_type":"4"}},{"id":2769983,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-29T19:18:35.000Z","date":"2021-03-26","kind":"sale","acquired":false,"shares":3389,"price":23.64,"value":80115.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $23.125 to $24.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2769,"source":{"system":"sec-edgar","filing":"0001209191-21-023482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121023482/doc4.xml","form_type":"4"}},{"id":2769982,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-29T19:18:35.000Z","date":"2021-03-26","kind":"exercise","acquired":true,"shares":4750,"price":0.04,"value":190.0,"ownership":{"direct":true},"balance_after":6158,"source":{"system":"sec-edgar","filing":"0001209191-21-023482","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121023482/doc4.xml","form_type":"4"}},{"id":2823382,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-03-02T17:37:55.000Z","date":"2021-02-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":12009,"derivative":{"exercise_price":0.04,"expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-016339","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121016339/doc4.xml","form_type":"4"}},{"id":2823381,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-02T17:37:55.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":68,"price":25.33,"value":1722.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.23 to $25.41. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1408,"source":{"system":"sec-edgar","filing":"0001209191-21-016339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121016339/doc4.xml","form_type":"4"}},{"id":2823380,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-02T17:37:55.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1372,"price":24.34,"value":33394.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.13 to $24.94. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1476,"source":{"system":"sec-edgar","filing":"0001209191-21-016339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121016339/doc4.xml","form_type":"4"}},{"id":2823379,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-02T17:37:55.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":3310,"price":23.73,"value":78546.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $23.08 to $24.075. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":2848,"source":{"system":"sec-edgar","filing":"0001209191-21-016339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121016339/doc4.xml","form_type":"4"}},{"id":2823378,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-03-02T17:37:55.000Z","date":"2021-02-26","kind":"exercise","acquired":true,"shares":4750,"price":0.04,"value":190.0,"ownership":{"direct":true},"balance_after":6158,"source":{"system":"sec-edgar","filing":"0001209191-21-016339","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121016339/doc4.xml","form_type":"4"}},{"id":2892756,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-28T16:36:58.000Z","date":"2021-01-26","kind":"exercise","acquired":false,"shares":4750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option are fully vested and exercisable."}],"balance_after":16759,"derivative":{"exercise_price":0.04,"expiration_date":"2025-04-23","underlying":"Common Stock","underlying_shares":4750},"source":{"system":"sec-edgar","filing":"0001209191-21-005892","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121005892/doc4.xml","form_type":"4"}},{"id":2892755,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-01-28T16:36:58.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":425,"price":25.94,"value":11024.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $25.885 to $26.60. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1408,"source":{"system":"sec-edgar","filing":"0001209191-21-005892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121005892/doc4.xml","form_type":"4"}},{"id":2892754,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-01-28T16:36:58.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":4325,"price":25.2,"value":108990.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $24.82 to $25.745. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":1833,"source":{"system":"sec-edgar","filing":"0001209191-21-005892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121005892/doc4.xml","form_type":"4"}},{"id":2892753,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2021-01-28T16:36:58.000Z","date":"2021-01-26","kind":"exercise","acquired":true,"shares":4750,"price":0.04,"value":190.0,"ownership":{"direct":true},"balance_after":6158,"source":{"system":"sec-edgar","filing":"0001209191-21-005892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919121005892/doc4.xml","form_type":"4"}},{"id":2929684,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-30T20:26:48.000Z","date":"2020-12-29","kind":"exercise","acquired":false,"shares":740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/4 of the shares subject to the option vested on March 4, 2018, and 1/48th of the shares vest monthly thereafter."}],"balance_after":91629,"derivative":{"exercise_price":1.79,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":740},"source":{"system":"sec-edgar","filing":"0001209191-20-065598","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919120065598/doc4.xml","form_type":"4"}},{"id":2929683,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":121082,"kind":"person","name":"Fairman Jeff","position":1,"cik":"0001813800","reported_name":"Fairman Jeff","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP, Research"}}],"security":"Common Stock","published_at":"2020-12-30T20:26:48.000Z","date":"2020-12-29","kind":"exercise","acquired":true,"shares":740,"price":1.79,"value":1324.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 668 shares acquired under the Employee Stock Purchase Plan on November 17, 2020."}],"balance_after":1408,"source":{"system":"sec-edgar","filing":"0001209191-20-065598","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813800/000120919120065598/doc4.xml","form_type":"4"}}]}